Summary
Introduction
Ruben Esse et al., DOT1L suppresses nuclear RNAi originating from enhancer elements in C. elegans pathways compete for the Dicer complex. We hypothesized that, upon loss of DOT-1.1 205 or ZFP-1, another pool of endogenous dsRNA (in addition to the RRF-3-produced) is 206 competing with exo-RNAi, and efficiency of the latter is reduced as a result of this 207 competition. To test this hypothesis, we used the elt-2::GFP/lacZ transgenic strain 208 (Fukushige et al., 1999) , which contains a repetitive transgenic array prone to silencing 209 through the Dicer/RDE-4/RDE-1 pathway (Grishok et al., 2005) . This transgene is 210 exclusively expressed in the nuclei of intestinal cells and shows partial silencing at 16°C 211 in the WT background and complete silencing in ERI pathway mutants (Grishok et al., 212 2005), such as eri-1(mg366) ( Figure 4A ). On the contrary, in zfp-1(ok554) (not shown) 213
or dot-1.1(gk520244) partial loss-of-function mutant backgrounds, it is readily apparent 214 that transgenic expression is increased compared to WT ( Figure 4A ). Importantly, the 215 level of GFP expression in the double mutant dot-1.1; eri-1 remains low, similar to that 216 of eri-1 alone ( Figure 4A ). This result indicates that the effect of dot-1.1 mutation (i.e. 217 transgene de-silencing) is suppressed by the loss of ERI-1 working together with Dicer. 218
In other words: DOT-1.1 acts upstream of ERI-1/Dicer. This result is not consistent with 219 the long-standing belief that ZFP-1 induces RNAi in the nucleus in response to siRNAs 220 produced by Dicer. However, it completely supports our hypothesis about the 221 mechanism of the apparent RNAi-promoting function of ZFP-1 and DOT-1.1. In 222 summary, our results demonstrate that, upon loss of ZFP-1/DOT-1.1, in addition to the 223 dsRNA generated through the ERI pathway and the dsRNA produced from transgenes, 224 the dsRNA produced from endogenous loci enters in the competition for the Dicercomplex ( Figure 4B ). Our data strongly suggest that this competition occurs in the 226 nucleus. 227
Loss of DOT-1.1 Results in Ectopic Heterochromatin at Distal and Intragenic 228
Enhancers 229 DOT1L activity has been shown to restrict the spreading of factors associated with 230 heterochromatin in yeast and leukemia cell lines (Chen et al., 2015; Katan-Khaykovich 231 and Struhl, 2005; Ng et al., 2002) . On the other hand, siRNAs direct Argonaute proteins 232 to complementary nascent transcripts to initiate H3K9 methylation, resulting in 233 heterochromatin formation (Grewal and Elgin, 2007; Ni et al., 2014) . We reasoned that 234 these two distinct phenomena could be put together in the context of the regulation of 235 enhancer transcription by ZFP-1/DOT-1.1. Interestingly, histone H3 lysine 9 236 dimethylation (H3K9me2), a hallmark of heterochromatin, is increased in both intragenic 237 and distal enhancers in dot-1.1; ced-3 animals compared to ced-3 animals ( Figures 5A  238 and 5B). In addition, genes displaying chromatin enhancer signatures and ZFP-1/DOT-239 1.1 binding have increased H3K9me2 in dot-1.1; ced-3 animals ( Figure 5C ). These 240 observations show that DOT1L activity prevents the encroachment of heterochromatin 241 to enhancer elements. 242
Discussion

243
In the past few years, genomic and transcriptomic data from high-throughput 244 sequencing studies have been shedding light on the importance of non-coding genomic 245 regulatory regions, including enhancers. These are typically demarcated by certain 246 characteristics, such as prevalence of the H3K4me1 and H3K27ac marks and openchromatin configuration, and these features have been extensively used to predict their 248 coordinates in a variety of organisms. Importantly, exciting new observations point to 249 the remarkable similarity between enhancers and promoters in terms of chromatin 250 architecture and transcriptional profile, challenging traditional binary views of enhancers 251 and promoters (Henriques et al., 2018; Mikhaylichenko et al., 2018; Rennie et al., 252 2017) . As these notions become dimmer, an interesting view gaining momentum is that 253 some enhancers can act as weak promoters, while, conversely, bidirectional promoters 254 often act as strong enhancers. This plasticity of enhancer and promoter activities is 255 manifested in the levels and directionality of transcription (Mikhaylichenko et al., 2018) . 256
In the face of this shifting paradigm, it is reasonable to speculate that the commonalities 257 between enhancers and promoters may extend to how their transcriptional output is 258 controlled by the epigenetic machinery of the cell, including molecular writers such as 259 histone methyltransferases and histone acetyltransferases. We had previously 260 demonstrated that ZFP-1/DOT-1.1 exert a negative modulatory role on transcription of 261 genes with promoter-proximal binding of the complex (Cecere et al., 2013) . These are 262 mostly highly and widely expressed genes not subject to spatiotemporal regulation. 263
Here, we present tantalizing evidence that the DOT1L complex also modulates 264 enhancer-directed transcription in a mechanism that likely partakes on the regulation of 265 genes subject to tissue and time-specific control of expression, ensuring the fidelity of 266 
